Amiodarone vs.Sotalol for Atrial Fibrillation:Cost-Effectiveness Analysis / 中国药房
China Pharmacy
;
(12)2005.
Artículo
en Chino
| WPRIM
| ID: wpr-530533
ABSTRACT
OBJECTIVE:
To evaluate the cost-effectiveness of amiodarone versus sotalol for Atrial fibrillation.METHODS:
A total of 102 patients with atrial fibrillation were treated with amiodarone(Group A)or sotalol(Group B).The cost-effectiveness analysis was performed on two groups.RESULTS:
The total cost in Group A was 2 714.18 yuan versus 2 176.56 yuan in Group B;the effective rates were 78.43% vs.70.59%(P
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Evaluación Económica en Salud
Idioma:
Chino
Revista:
China Pharmacy
Año:
2005
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS